Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) has shared an announcement.
Theracryf PLC, a UK-based company, has announced a significant change in its voting rights structure due to an acquisition or disposal of voting rights by Rathbones Investment Management Ltd and Investec Wealth & Investment Limited. The notification indicates that the total voting rights held by these entities have decreased from 6.0347% to 1.1662%, suggesting a substantial reduction in their influence over the company’s decisions. This change could impact the company’s governance and strategic direction, potentially affecting stakeholders and market perceptions.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 1,889,140
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For detailed information about TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue